The Stock for 1999(Polymedica)PLMD(Medical Supply Co.) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : The Stock for 1999(Polymedica)PLMD(Medical Supply Co.)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Alan Newman who wrote (1313)	7/3/1998 11:35:00 AM
From: Abuckatatime	Read Replies (3) of 3414

Alan, Zacks posted more info re Josephthal's estimates for FY 99 so now we have them for six consecutive upcoming quarters. PM: JOSEPHTHAL & CO decreased estimate for quarter ending 06/98 from $0.14 to $0.12 on 07/01/98 PM: JOSEPHTHAL & CO decreased estimate for quarter ending 09/98 from $0.15 to $0.13 on 07/01/98 PM: JOSEPHTHAL & CO increased estimate for quarter ending 12/98 from $0.17 to $0.19 on 07/01/98 PM: JOSEPHTHAL & CO increased estimate for quarter ending 03/99 from $0.18 to $0.22 on 07/01/98 PM: JOSEPHTHAL & CO increased estimate for fiscal year ending 03/99 from $0.64 to $0.65 on 07/01/98 PM: JOSEPHTHAL & CO has reiterated estimate for quarter ending 06/99 of $0.17 on 07/01/98 PM: JOSEPHTHAL & CO has reiterated estimate for quarter ending 09/99 of $0.19 on 07/01/98 PM: JOSEPHTHAL & CO increased estimate for quarter ending 12/99 from $0.22 to $0.23 on 07/01/98 As you indicated Josephthal lowered estimates for the first two quarters of this fiscal year, consistent with Lee's projections, and with those of Cruttenden Roth and Oscar Gruss, but increased estimates for the last two quarters and for the year ( note that quarterly estimates add to $.66, not $.65!). Summing estimates over the first three quarters of each fiscal year and comparing them shows that Josephthal projects earnings growth of over 30%. Extrapolation suggests FY2000 eps of roughly $.85. In the last press release Lee gave guidance regarding earnings for the first quarter and reasons for a dip in sequential quarterly results. IMO we are looking at a stock price that already discounts for this dip but does not reflect a valuation appropriate for a company growing earnings at 30% or more on an annual basis. Assuming that earnings for Q1 match or better consensus estimates and that receivables are improving as predicted, I expect to see a more reasonable multiple. Greg

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next